Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.84 Analyst target: $9.00 Upside: 971.43%
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.
See the full interactive analysis & chart →Informational only — not investment advice.